FOXP1 and ovarian carcinoma: For instance, downregulation of FOXP1 is associated with aggressive tumor behavior, resulting in poor prognosis in colorectal neoplasia [17], prostate cancer [20], endometrial [31], ovarian cancer [32], and renal cell carcinoma [33].